Company Filing History:
Years Active: 2010
Title: The Innovations of Stephen R Brych
Introduction
Stephen R Brych is a notable inventor based in Simi Valley, California. He has made significant contributions to the field of biomedical research, particularly in the development of engineered human acidic fibroblast growth factors. His work has implications for various medical applications, showcasing the potential of innovative biotechnological advancements.
Latest Patents
Stephen R Brych holds a patent for "Engineered human acidic fibroblast growth factors and associated methods." This patent describes an engineered, purified polypeptide of acidic fibroblast growth factor (FGF-1), which possesses an amino acid sequence that consists essentially of SEQ ID NO: 1. The engineered polypeptide demonstrates 70 times the mitogenic activity of the wild type acidic fibroblast growth factor. Additionally, other engineered FGFs with altered properties, including reduced heparin binding affinity and increased mitogenicity, have been developed, as evidenced by studies using a model mammalian cell line derived from mice, NIH 3T3 fibroblasts. He has 1 patent to his name.
Career Highlights
Stephen R Brych is affiliated with the Florida State University Research Foundation, Inc., where he continues to advance his research in growth factors and their applications. His work is characterized by a commitment to enhancing our understanding of cellular growth and development.
Collaborations
One of his notable collaborators is Michael Blaber, with whom he has worked on various research projects. Their combined expertise has contributed to the advancement of knowledge in the field of fibroblast growth factors.
Conclusion
Stephen R Brych's innovative work in engineered human acidic fibroblast growth factors exemplifies the impact of research on medical science. His contributions continue to pave the way for future advancements in biotechnology and therapeutic applications.